Zobrazeno 1 - 10
of 190
pro vyhledávání: '"Hidenori NAKAMURA"'
Publikováno v:
Discover Sustainability, Vol 5, Iss 1, Pp 1-21 (2024)
Abstract This study explores the potential of cross-border citizen dialogues on the Sustainable Development Goals (SDGs) for uncovering cultural barriers and catalysts in sustainability transformations. We utilised a form adapted from the Open Dialog
Externí odkaz:
https://doaj.org/article/d206cbefd45b4dbf8b0aefe3aa187675
Autor:
Kohei Shikano, Mitsuhiro Abe, Ryutaro Hirama, Shinsuke Kitahara, Kanae Maruyama, Dai Horiuchi, Noriko Sakuma, Daisuke Ishii, Takeshi Kawasaki, Hidenori Nakamura, Takuji Suzuki
Publikováno v:
The Clinical Respiratory Journal, Vol 17, Iss 8, Pp 733-739 (2023)
Abstract Introduction Secondary spontaneous pneumothorax (SSP) occurs as one of the complications associated with interstitial pneumonia (IP). Chest drainage is performed when there is a large volume of air in the pleural space. Notably, SSP with IP
Externí odkaz:
https://doaj.org/article/ec257ad0a4a0444ba50184e6ff2d9810
Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis
Autor:
Yuzo Suzuki, Atsuki Fukada, Kazutaka Mori, Masato Kono, Hirotsugu Hasegawa, Dai Hashimoto, Koshi Yokomura, Shiro Imokawa, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
ERJ Open Research, Vol 9, Iss 3 (2023)
Background Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is characterised by upper lobe-dominant fibrosis involving the pleura and subpleural lung parenchyma, with advanced cases often complicated by progressive weight loss. Therefore, we hypot
Externí odkaz:
https://doaj.org/article/73ec037f13204ed99b126dbcaadb79e3
Autor:
Ayu Ito, Shoko Itakura, Yuya Hasegawa, Miyu Hashimoto, Akie Okada, Mamoru Hirafuji, Hidenori Nakamura, Kenji Sugibayashi, Hiroaki Todo
Publikováno v:
Frontiers in Drug Delivery, Vol 3 (2023)
Patients receiving chemotherapy by intravenous (i.v.) or oral administration of anticancer drugs often experience side effects. In this study, an electro-osmotic flow (EO) pump was used for the direct administration of an anticancer drug with minimum
Externí odkaz:
https://doaj.org/article/4bb2d619a61945f5bc998ac069e0bd7b
Autor:
Takafumi Koyauchi, Yuzo Suzuki, Kazuki Sato, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Koshi Yokomura, Shiro Imokawa, Hidenori Nakamura, Tatsuya Morita, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Respiratory modalities applied at the end of life may affect the burden of distressing symptoms and quality of dying and death (QODD) among patients with end-stage interstitial lung disease (ILD); however, there have been few stud
Externí odkaz:
https://doaj.org/article/486276099272449ead0608b524843724
Autor:
Hironao Hozumi, Masato Kono, Hirotsugu Hasegawa, Shinpei Kato, Yusuke Inoue, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Koshi Yokomura, Hidenori Nakamura, Takafumi Suda
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute exacerbation (AE)—a rapidly progressing and deadly respirat
Externí odkaz:
https://doaj.org/article/a8897a8aab0f430daf446a88dfc21706
Autor:
Kenichiro Takeda, Hideki Miwa, Masato Kono, Ryutaro Hirama, Yuiko Oshima, Yasutaka Mochizuka, Akari Tsutsumi, Yoshihiro Miki, Dai Hashimoto, Hidenori Nakamura
Publikováno v:
Respiratory Medicine Case Reports, Vol 42, Iss , Pp 101824- (2023)
A 75-year-old woman was admitted to our hospital with progressive dyspnea 7 months after second-line treatment with pembrolizumab for advanced non-small cell lung cancer. Chest radiography revealed hyperinflation in both lung fields, and pulmonary fu
Externí odkaz:
https://doaj.org/article/dab07bb4ac874354a24c92f94c11be13
Autor:
Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Antifibrotic therapy (AFT) slows disease progression in patients with idiopathic pulmonary fibrosis (IPF). The Gender-Age-Physiology (GAP) index, was developed based on data at IPF diagnosis before the introduction of AFT and has not been ev
Externí odkaz:
https://doaj.org/article/e4053b1dc1be411488281f1878f5b551
Autor:
Yuzo Suzuki, Kazutaka Mori, Yuya Aono, Masato Kono, Hirotsugu Hasegawa, Koshi Yokomura, Hyogo Naoi, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura, Naoki Inui, Hidenori Nakamura, Takafumi Suda
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Currently, there are two antifibrotics used to treat idiopathic pulmonary fibrosis (IPF): pirfenidone and nintedanib. Antifibrotics slow disease progression by reducing the annual decline of forced vital capacity (FVC), which poss
Externí odkaz:
https://doaj.org/article/4dbda5c1c00342a09b5cd06cd44651aa
Autor:
Takahito Suzuki, Hironao Hozumi, Koichi Miyashita, Masato Kono, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Hirotsugu Hasegawa, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Koshi Yokomura, Hidenori Nakamura, Takafumi Suda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is a major prognostic determinant. However, evidence for its prognostic strength is mainly based on the results of small cohort studies with statistical limitations. This retrosp
Externí odkaz:
https://doaj.org/article/0e0643371bdb413c96c5184a22bb1dc7